| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 2.29e-07 | 4 | 78 | 3 | GO:0015016 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 2.29e-07 | 4 | 78 | 3 | GO:0050119 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 2.52e-05 | 15 | 78 | 3 | GO:0034483 | |
| GeneOntologyMolecularFunction | heparan sulfate N-deacetylase activity | 4.51e-05 | 3 | 78 | 2 | GO:0102140 | |
| GeneOntologyMolecularFunction | deacetylase activity | 5.11e-04 | 40 | 78 | 3 | GO:0019213 | |
| GeneOntologyMolecularFunction | integrin binding | 6.15e-04 | 175 | 78 | 5 | GO:0005178 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 2.87e-06 | 8 | 78 | 3 | GO:0015014 | |
| GeneOntologyBiologicalProcess | heparin biosynthetic process | 8.40e-06 | 11 | 78 | 3 | GO:0030210 | |
| GeneOntologyBiologicalProcess | heparin metabolic process | 3.41e-05 | 17 | 78 | 3 | GO:0030202 | |
| Domain | HSNSD | 2.90e-07 | 4 | 79 | 3 | PF12062 | |
| Domain | Heparan_SO4_deacetylase | 2.90e-07 | 4 | 79 | 3 | IPR021930 | |
| Domain | VWA | 3.84e-06 | 56 | 79 | 5 | PF00092 | |
| Domain | VWFA | 2.52e-05 | 82 | 79 | 5 | PS50234 | |
| Domain | VWA | 2.83e-05 | 84 | 79 | 5 | SM00327 | |
| Domain | VWF_A | 6.24e-05 | 99 | 79 | 5 | IPR002035 | |
| Domain | VWA_N | 1.75e-04 | 5 | 79 | 2 | IPR013608 | |
| Domain | VWA_N | 1.75e-04 | 5 | 79 | 2 | PF08399 | |
| Domain | Cullin_CS | 3.66e-04 | 7 | 79 | 2 | IPR016157 | |
| Domain | Sulfotransferase_dom | 4.70e-04 | 36 | 79 | 3 | IPR000863 | |
| Domain | Sulfotransfer_1 | 4.70e-04 | 36 | 79 | 3 | PF00685 | |
| Domain | Cullin_Nedd8 | 4.87e-04 | 8 | 79 | 2 | PF10557 | |
| Domain | Cullin_Nedd8 | 4.87e-04 | 8 | 79 | 2 | SM00884 | |
| Domain | Cullin_neddylation_domain | 4.87e-04 | 8 | 79 | 2 | IPR019559 | |
| Domain | Cullin_homology | 6.24e-04 | 9 | 79 | 2 | IPR016158 | |
| Domain | Cullin | 7.78e-04 | 10 | 79 | 2 | PF00888 | |
| Domain | CULLIN_2 | 7.78e-04 | 10 | 79 | 2 | PS50069 | |
| Domain | Cullin_N | 7.78e-04 | 10 | 79 | 2 | IPR001373 | |
| Domain | CULLIN_1 | 7.78e-04 | 10 | 79 | 2 | PS01256 | |
| Domain | PSI | 8.51e-04 | 44 | 79 | 3 | IPR016201 | |
| Domain | Integrin_alpha | 9.48e-04 | 11 | 79 | 2 | PF00357 | |
| Domain | PSI | 9.70e-04 | 46 | 79 | 3 | SM00423 | |
| Domain | Integrin_alpha_C_CS | 2.04e-03 | 16 | 79 | 2 | IPR018184 | |
| Domain | ConA-like_dom | 2.36e-03 | 219 | 79 | 5 | IPR013320 | |
| Domain | Integrin_alpha-2 | 2.59e-03 | 18 | 79 | 2 | IPR013649 | |
| Domain | Integrin_alpha2 | 2.59e-03 | 18 | 79 | 2 | PF08441 | |
| Domain | Integrin_alpha | 2.59e-03 | 18 | 79 | 2 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 2.59e-03 | 18 | 79 | 2 | PS00242 | |
| Domain | Int_alpha_beta-p | 2.88e-03 | 19 | 79 | 2 | IPR013519 | |
| Domain | Int_alpha | 2.88e-03 | 19 | 79 | 2 | SM00191 | |
| Domain | Semaphorin | 3.19e-03 | 20 | 79 | 2 | IPR027231 | |
| Domain | - | 3.81e-03 | 74 | 79 | 3 | 3.40.50.410 | |
| Domain | FG_GAP | 3.86e-03 | 22 | 79 | 2 | PS51470 | |
| Domain | FG-GAP | 4.59e-03 | 24 | 79 | 2 | PF01839 | |
| Domain | FG-GAP | 4.59e-03 | 24 | 79 | 2 | IPR013517 | |
| Domain | Integrin_dom | 4.98e-03 | 25 | 79 | 2 | IPR032695 | |
| Domain | SPRY | 5.98e-03 | 87 | 79 | 3 | SM00449 | |
| Domain | EGF_LAM_2 | 7.12e-03 | 30 | 79 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 7.12e-03 | 30 | 79 | 2 | PS01248 | |
| Domain | SPRY | 7.41e-03 | 94 | 79 | 3 | PF00622 | |
| Domain | SPRY_dom | 7.41e-03 | 94 | 79 | 3 | IPR003877 | |
| Domain | Sema | 7.59e-03 | 31 | 79 | 2 | SM00630 | |
| Domain | Semap_dom | 7.59e-03 | 31 | 79 | 2 | IPR001627 | |
| Domain | Sema | 7.59e-03 | 31 | 79 | 2 | PF01403 | |
| Domain | SEMA | 7.59e-03 | 31 | 79 | 2 | PS51004 | |
| Domain | B30.2/SPRY | 7.63e-03 | 95 | 79 | 3 | IPR001870 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS | 1.37e-05 | 11 | 63 | 3 | M47921 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE | 2.06e-04 | 26 | 63 | 3 | M7330 | |
| Pathway | WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS | 2.30e-04 | 27 | 63 | 3 | M45550 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 2.86e-04 | 29 | 63 | 3 | MM14802 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 3.50e-04 | 31 | 63 | 3 | M685 | |
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 22049073 | ||
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 12070138 | ||
| Pubmed | 1.12e-07 | 5 | 79 | 3 | 11087757 | ||
| Pubmed | FGF signaling sustains the odontogenic fate of dental mesenchyme by suppressing β-catenin signaling. | 6.27e-07 | 8 | 79 | 3 | 24067353 | |
| Pubmed | Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain. | 1.84e-06 | 11 | 79 | 3 | 15944372 | |
| Pubmed | 2.45e-06 | 12 | 79 | 3 | 12460940 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NPC1 NDST1 CACNA2D1 FAP SEMA3C FANCI UGGT1 FKBP9 LAMA4 CACHD1 ECE1 SLC33A1 FRMD5 | 2.96e-06 | 1201 | 79 | 13 | 35696571 |
| Pubmed | N-sulfation of heparan sulfate regulates early branching events in the developing mammary gland. | 5.09e-06 | 2 | 79 | 2 | 23060443 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 10758005 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 12634318 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 8144627 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 9565617 | ||
| Pubmed | Undersulfation of heparan sulfate restricts differentiation potential of mouse embryonic stem cells. | 5.09e-06 | 2 | 79 | 2 | 22298785 | |
| Pubmed | Protein tyrosine phosphatase PTPN22 regulates LFA-1 dependent Th1 responses. | 5.09e-06 | 2 | 79 | 2 | 30054208 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 15319440 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 16984905 | ||
| Pubmed | Heparin/heparan sulfate biosynthesis: processive formation of N-sulfated domains. | 5.09e-06 | 2 | 79 | 2 | 18487608 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 SERPINB6 MYO9A GPR137B MACF1 SCAF11 ADGRV1 PPM1K CAMTA1 CLEC16A STAG2 HNRNPL SBNO2 PDZD2 | 5.99e-06 | 1489 | 79 | 14 | 28611215 |
| Pubmed | Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development. | 1.25e-05 | 20 | 79 | 3 | 17107998 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 22345168 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 9915799 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 18479348 | ||
| Pubmed | 1.67e-05 | 493 | 79 | 8 | 15368895 | ||
| Pubmed | NDST1-dependent heparan sulfate regulates BMP signaling and internalization in lung development. | 1.68e-05 | 22 | 79 | 3 | 19299468 | |
| Pubmed | SHARPIN regulates uropod detachment in migrating lymphocytes. | 3.05e-05 | 4 | 79 | 2 | 24210817 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 29688404 | ||
| Pubmed | Heparan sulfate structure in mice with genetically modified heparan sulfate production. | 3.05e-05 | 4 | 79 | 2 | 15292174 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 34333526 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 16056228 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 19737859 | ||
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 15210787 | ||
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 37781399 | ||
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 17289920 | ||
| Pubmed | CD11c regulates hematopoietic stem and progenitor cells under stress. | 5.07e-05 | 5 | 79 | 2 | 33351105 | |
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 19915053 | ||
| Pubmed | 9.61e-05 | 814 | 79 | 9 | 23251661 | ||
| Pubmed | Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis. | 9.72e-05 | 39 | 79 | 3 | 19738611 | |
| Pubmed | A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. | 1.06e-04 | 7 | 79 | 2 | 17632545 | |
| Pubmed | Altered heparan sulfate structure in mice with deleted NDST3 gene function. | 1.06e-04 | 7 | 79 | 2 | 18385133 | |
| Pubmed | The methionine synthase (Mtr) gene maps to proximal mouse chromosome 13. | 1.06e-04 | 7 | 79 | 2 | 9321480 | |
| Pubmed | Chondroitin sulfate enhances the barrier function of basement membrane assembled by heparan sulfate. | 1.06e-04 | 7 | 79 | 2 | 35608020 | |
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 24451376 | ||
| Pubmed | 1.20e-04 | 653 | 79 | 8 | 22586326 | ||
| Pubmed | 1.41e-04 | 8 | 79 | 2 | 8562500 | ||
| Pubmed | Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. | 1.41e-04 | 8 | 79 | 2 | 19264985 | |
| Pubmed | 1.41e-04 | 8 | 79 | 2 | 20006658 | ||
| Pubmed | NPC1 PPARGC1A ATRNL1 UGGT1 MACF1 HERC1 CAMTA1 SLC33A1 STAG2 SBNO2 | 1.70e-04 | 1084 | 79 | 10 | 11544199 | |
| Pubmed | Genetic epistasis between heparan sulfate and FGF-Ras signaling controls lens development. | 1.82e-04 | 9 | 79 | 2 | 21536023 | |
| Pubmed | A mutant-cell library for systematic analysis of heparan sulfate structure-function relationships. | 1.82e-04 | 9 | 79 | 2 | 30377379 | |
| Pubmed | 2.25e-04 | 130 | 79 | 4 | 12421765 | ||
| Pubmed | Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis. | 2.27e-04 | 10 | 79 | 2 | 19951419 | |
| Pubmed | Skp2-Mediated Stabilization of MTH1 Promotes Survival of Melanoma Cells upon Oxidative Stress. | 2.30e-04 | 52 | 79 | 3 | 28947420 | |
| Pubmed | Class 3 semaphorins negatively regulate dermal lymphatic network formation. | 2.76e-04 | 11 | 79 | 2 | 26319580 | |
| Pubmed | 2.76e-04 | 11 | 79 | 2 | 26625197 | ||
| Pubmed | 2.76e-04 | 11 | 79 | 2 | 10926765 | ||
| Pubmed | Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals. | 3.16e-04 | 142 | 79 | 4 | 19851296 | |
| Pubmed | Association of genetic variants with hemorrhagic stroke in Japanese individuals. | 3.24e-04 | 143 | 79 | 4 | 20198315 | |
| Pubmed | 3.31e-04 | 12 | 79 | 2 | 19812329 | ||
| Pubmed | 3.31e-04 | 12 | 79 | 2 | 23991118 | ||
| Pubmed | 3.31e-04 | 12 | 79 | 2 | 18077586 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ACSL3 CUL1 KNTC1 FANCI UGGT1 SCAMP2 FGD5 HNRNPUL1 STAG2 HNRNPL MGAM2 | 3.68e-04 | 1425 | 79 | 11 | 30948266 |
| Pubmed | 3.87e-04 | 62 | 79 | 3 | 19710015 | ||
| Pubmed | 4.08e-04 | 152 | 79 | 4 | 34299191 | ||
| Pubmed | 4.55e-04 | 14 | 79 | 2 | 22653443 | ||
| Pubmed | 4.55e-04 | 14 | 79 | 2 | 36347239 | ||
| Pubmed | 4.90e-04 | 285 | 79 | 5 | 32838362 | ||
| Pubmed | 5.25e-04 | 15 | 79 | 2 | 19536649 | ||
| Pubmed | Whole genome association scan for genetic polymorphisms influencing information processing speed. | 5.99e-04 | 16 | 79 | 2 | 21130836 | |
| Pubmed | Expression of the semaphorins Sema 3D and Sema 3F in the developing parathyroid and thymus. | 5.99e-04 | 16 | 79 | 2 | 18489001 | |
| Pubmed | 6.03e-04 | 634 | 79 | 7 | 34591612 | ||
| Pubmed | 6.20e-04 | 1049 | 79 | 9 | 27880917 | ||
| Pubmed | 6.78e-04 | 17 | 79 | 2 | 20395553 | ||
| Pubmed | Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. | 6.78e-04 | 17 | 79 | 2 | 17554260 | |
| Pubmed | 6.78e-04 | 17 | 79 | 2 | 14741744 | ||
| Pubmed | NPC1 CACNA2D1 AIFM2 SERPINB6 UGGT1 LAMA4 ELF5 ECE1 SPATA32 SBNO2 | 6.84e-04 | 1293 | 79 | 10 | 15342556 | |
| Pubmed | 6.98e-04 | 650 | 79 | 7 | 38777146 | ||
| Pubmed | NPC1 ACSL3 CACNA2D1 SEMA3C SERPINB6 UGGT1 FKBP9 MACF1 HNRNPUL1 ECE1 | 7.00e-04 | 1297 | 79 | 10 | 33545068 | |
| Pubmed | 8.47e-04 | 81 | 79 | 3 | 39217171 | ||
| Pubmed | PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. | 8.50e-04 | 19 | 79 | 2 | 15239958 | |
| Pubmed | 9.43e-04 | 20 | 79 | 2 | 22745308 | ||
| Pubmed | Role of heparan sulfate proteoglycans in optic disc and stalk morphogenesis. | 9.43e-04 | 20 | 79 | 2 | 24753163 | |
| Pubmed | Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. | 9.43e-04 | 20 | 79 | 2 | 18978792 | |
| Pubmed | Shared and distinct genetic variants in type 1 diabetes and celiac disease. | 1.04e-03 | 21 | 79 | 2 | 19073967 | |
| Pubmed | Motor neurons use push-pull signals to direct vascular remodeling critical for their connectivity. | 1.04e-03 | 21 | 79 | 2 | 36240771 | |
| Pubmed | 1.14e-03 | 22 | 79 | 2 | 26631746 | ||
| Pubmed | mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTOR. | 1.25e-03 | 23 | 79 | 2 | 22017875 | |
| Pubmed | 1.25e-03 | 23 | 79 | 2 | 20301575 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 1.25e-03 | 719 | 79 | 7 | 35337019 | |
| Pubmed | Genes expressed in Atoh1 neuronal lineages arising from the r1/isthmus rhombic lip. | 1.34e-03 | 95 | 79 | 3 | 21440680 | |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 1.34e-03 | 95 | 79 | 3 | 29643511 | |
| Pubmed | A general approach for investigating enzymatic pathways and substrates for ubiquitin-like modifiers. | 1.36e-03 | 24 | 79 | 2 | 16620772 | |
| Pubmed | 1.36e-03 | 24 | 79 | 2 | 34653670 | ||
| Pubmed | 1.37e-03 | 730 | 79 | 7 | 34857952 | ||
| Pubmed | 1.46e-03 | 214 | 79 | 4 | 22199357 | ||
| Pubmed | Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. | 1.48e-03 | 25 | 79 | 2 | 21829393 | |
| Pubmed | Klf4 glutamylation is required for cell reprogramming and early embryonic development in mice. | 1.48e-03 | 25 | 79 | 2 | 29593216 | |
| Pubmed | Single-cell analysis of cardiogenesis reveals basis for organ-level developmental defects. | 1.48e-03 | 25 | 79 | 2 | 31341279 | |
| Pubmed | ACSL3 CUL1 KNTC1 CACNA2D1 CCNE2 FANCI UGGT1 HNRNPUL1 STAG2 HNRNPL | 1.54e-03 | 1440 | 79 | 10 | 30833792 | |
| Pubmed | 1.65e-03 | 102 | 79 | 3 | 31623628 | ||
| Pubmed | 1.72e-03 | 27 | 79 | 2 | 34709416 | ||
| GeneFamily | Sulfotransferases, membrane bound | 2.49e-04 | 37 | 60 | 3 | 763 | |
| GeneFamily | Cullins | 2.99e-04 | 8 | 60 | 2 | 1032 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 1.60e-03 | 18 | 60 | 2 | 1160 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 1.98e-03 | 20 | 60 | 2 | 736 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 1.98e-03 | 20 | 60 | 2 | 548 | |
| GeneFamily | Serpin peptidase inhibitors | 6.69e-03 | 37 | 60 | 2 | 739 | |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP | 2.74e-06 | 130 | 79 | 6 | M6590 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | KNTC1 PPARGC1A FAP SEMA3C SACS MYO9A SCAF11 TRPM1 STAG2 KIF20B | 2.74e-05 | 656 | 79 | 10 | M18979 |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN | 3.20e-05 | 200 | 79 | 6 | M5167 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 4.34e-05 | 426 | 79 | 8 | M9516 | |
| Coexpression | PEART_HDAC_PROLIFERATION_CLUSTER_DN | 6.37e-05 | 71 | 79 | 4 | M1421 | |
| Coexpression | YANG_BCL3_TARGETS_UP | 6.64e-05 | 333 | 79 | 7 | M2424 | |
| Coexpression | MULLIGHAN_NPM1_SIGNATURE_3_UP | 6.90e-05 | 335 | 79 | 7 | M10277 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-08 | 180 | 79 | 7 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-07 | 179 | 79 | 6 | 80112c686a8f85ad5e3cda6e3f3d3d51cf688092 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.24e-06 | 193 | 79 | 6 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.88e-06 | 157 | 79 | 5 | a633fb8e7a009490c6002bf272eceaf317f27af6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 167 | 79 | 5 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 167 | 79 | 5 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 168 | 79 | 5 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-05 | 168 | 79 | 5 | 4c402a1613fcf0a6e4d9b9d5551812940e91ff32 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.46e-05 | 174 | 79 | 5 | b7f5492ce8098f7eb0aef30ee558d00738d59d0e | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.46e-05 | 174 | 79 | 5 | 71730503be3d9c839c4c9e950145e2101d682a1c | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.46e-05 | 174 | 79 | 5 | ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.46e-05 | 174 | 79 | 5 | cafe4d6b5f08d8888e9db6e196c66df991c03e7b | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 176 | 79 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-05 | 178 | 79 | 5 | 462111b61f37338f97ac7dc6c7da1d4316b54445 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-05 | 180 | 79 | 5 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 182 | 79 | 5 | 11494a66d986297b837332ee9d382b71b9f22591 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.91e-05 | 184 | 79 | 5 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.96e-05 | 185 | 79 | 5 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 186 | 79 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 187 | 79 | 5 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 187 | 79 | 5 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 187 | 79 | 5 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 187 | 79 | 5 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 2.17e-05 | 189 | 79 | 5 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 189 | 79 | 5 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | moderate-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.17e-05 | 189 | 79 | 5 | 22a19365782003c18ec8dddcdbfdaa82c4e330f6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 189 | 79 | 5 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.29e-05 | 191 | 79 | 5 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | Endothelial-C|World / shred on cell class and cell subclass (v4) | 2.29e-05 | 191 | 79 | 5 | bf203931f973098b79ec681d1dd0854419819e98 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.40e-05 | 193 | 79 | 5 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.40e-05 | 193 | 79 | 5 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.46e-05 | 194 | 79 | 5 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.46e-05 | 194 | 79 | 5 | 12496bc964d1c572241410524a89ca1a9fdb7e34 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-05 | 194 | 79 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | PND07-Endothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.46e-05 | 194 | 79 | 5 | d1080c86884916c22894b27994141463f5919812 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.46e-05 | 194 | 79 | 5 | f93f5148b136819d87faef89707dbaba07d6c2b5 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.52e-05 | 195 | 79 | 5 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.52e-05 | 195 | 79 | 5 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.52e-05 | 195 | 79 | 5 | 4658fb197657d7692ee344ae76b11b0210c418ba | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 2.52e-05 | 195 | 79 | 5 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.52e-05 | 195 | 79 | 5 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.52e-05 | 195 | 79 | 5 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 195 | 79 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.65e-05 | 197 | 79 | 5 | 62c0a90869431e582bb7bb329e0b0cc59123d3d1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.65e-05 | 197 | 79 | 5 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.65e-05 | 197 | 79 | 5 | 16f0eb047df9d702518f82ee99c6e7dc1350b2fb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.72e-05 | 198 | 79 | 5 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK|World / disease group, cell group and cell class (v2) | 2.72e-05 | 198 | 79 | 5 | 7a0aac52d785037455e068e1b25de4b2bf0fff79 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.72e-05 | 198 | 79 | 5 | 7cddd474416651088a4e08edfc0ac420ff10a5fe | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.85e-05 | 200 | 79 | 5 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 2.85e-05 | 200 | 79 | 5 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.85e-05 | 200 | 79 | 5 | 030efc36bbb848da31b0db3f74d46aac9c79cc9b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.85e-05 | 200 | 79 | 5 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | PSB-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.85e-05 | 200 | 79 | 5 | 3e3de496508efb2f95e5e8684f97687381e96493 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.85e-05 | 200 | 79 | 5 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.85e-05 | 200 | 79 | 5 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.04e-05 | 100 | 79 | 4 | 60c2bdee5d37dedf9be1e03b6b52b539a2277df3 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.16e-05 | 101 | 79 | 4 | de49feca7548640f85d206ebc56a58ab0bf7ac16 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.07e-04 | 138 | 79 | 4 | 93497c0a5d5e54006653b2dedc7a7041e1a613e6 | |
| ToppCell | IIH-CD4-CD8_1|IIH / Condition, Cell_class and T cell subcluster | 1.29e-04 | 145 | 79 | 4 | 296b6b0eea3233d76742ea35252b2f54d4c27ab6 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-04 | 145 | 79 | 4 | b17699f7f98d2361a4d26c26f52db05e7ff69dff | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-04 | 151 | 79 | 4 | 2dc132895609e4efe17954e31f53d9c1ccf256ef | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-04 | 151 | 79 | 4 | 22afd8201eff8471da3456be065f2790de5e4bfe | |
| ToppCell | COVID-19_Severe-B_cell|COVID-19_Severe / disease group, cell group and cell class | 1.58e-04 | 153 | 79 | 4 | 701a7d92ee7b22277c8462742a530347cc6f061a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 155 | 79 | 4 | 969fc4c98a96bf2f436e8e63d4deb2183ef3b864 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-04 | 156 | 79 | 4 | ff39712c7a2dc1b85c598d5105789aa291dea726 | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 159 | 79 | 4 | 51bdbacb79227fbee38bb8680c58cb99878df0c7 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-04 | 164 | 79 | 4 | 3cd80e6275f0f9b5667912139d15ebf5e6b17f2f | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.12e-04 | 165 | 79 | 4 | 7d319a112b9062efee428bef6f4534d2ce782e04 | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 168 | 79 | 4 | 18c266162a879544c0103d9dff0270af68964f9e | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 2.27e-04 | 168 | 79 | 4 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 168 | 79 | 4 | cb1506cd43a4f36f9024cc9b8e5319365498d244 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-04 | 169 | 79 | 4 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-04 | 169 | 79 | 4 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.32e-04 | 169 | 79 | 4 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-04 | 169 | 79 | 4 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-B_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.42e-04 | 171 | 79 | 4 | bd1ebd9037a740ad8c01c460d778b0973d8b56df | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 171 | 79 | 4 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.42e-04 | 171 | 79 | 4 | bf475a69db04d4a886e442704955c6a96ff0de46 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 171 | 79 | 4 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | Immune_cells-pro-B|Immune_cells / Lineage and Cell class | 2.48e-04 | 172 | 79 | 4 | 096636f2589fa56d15942aac96641c16fd5fa78d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.53e-04 | 173 | 79 | 4 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.53e-04 | 173 | 79 | 4 | 2e9dc137f3675eee07f941eb4cfcaf24a83ab0fb | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.53e-04 | 173 | 79 | 4 | 3a9e9a09b3eeb37cbe56d650e112a8398879477f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-04 | 174 | 79 | 4 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-04 | 174 | 79 | 4 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.59e-04 | 174 | 79 | 4 | 5e6050d20a5b27640f6a200441125b8ceba123c8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.59e-04 | 174 | 79 | 4 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 2.65e-04 | 175 | 79 | 4 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.65e-04 | 175 | 79 | 4 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-04 | 175 | 79 | 4 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.65e-04 | 175 | 79 | 4 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.65e-04 | 175 | 79 | 4 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.70e-04 | 176 | 79 | 4 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-04 | 176 | 79 | 4 | 1df7b6ce2519ad99bacbbaf1a8d5929e11513faa | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.70e-04 | 176 | 79 | 4 | 27e6b3ae41068d6cfdda3d46da7df2a27567140e | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.70e-04 | 176 | 79 | 4 | d6a5470af9592f34a741265f2ea9651c05c3add3 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-04 | 178 | 79 | 4 | 804ac3725c1f88e2212172bfb9aa01d97a735621 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-04 | 178 | 79 | 4 | ad6dc4a375664c919bd48c35c48a561fc5a7de8c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-04 | 179 | 79 | 4 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; HL60; HG-U133A | 4.11e-06 | 193 | 77 | 7 | 1982_DN | |
| Disease | azoospermia (implicated_via_orthology) | 4.42e-05 | 27 | 75 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | Addison's disease (is_implicated_in) | 6.34e-05 | 5 | 75 | 2 | DOID:13774 (is_implicated_in) | |
| Disease | thalamus volume | 6.67e-05 | 85 | 75 | 4 | EFO_0006935 | |
| Disease | red blood cell density measurement | RALGAPA1 PPARGC1A SEMA3C MYO9A FKBP9 FGD5 ADGRV1 CAMTA1 ATP8B2 KIF20B | 7.60e-05 | 880 | 75 | 10 | EFO_0007978 |
| Disease | glucagon measurement, glucose tolerance test | 9.50e-05 | 6 | 75 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | hearing impairment | 1.16e-04 | 98 | 75 | 4 | C1384666 | |
| Disease | postcentral gyrus volume measurement | 2.27e-04 | 9 | 75 | 2 | EFO_0010323 | |
| Disease | waist-hip ratio | NPC1 AGBL4 KNTC1 NDST1 SEMA3C AIFM2 LAMA4 TBX10 CUL9 ECE1 CLEC16A | 2.60e-04 | 1226 | 75 | 11 | EFO_0004343 |
| Disease | renal fibrosis (biomarker_via_orthology) | 4.14e-04 | 12 | 75 | 2 | DOID:0050855 (biomarker_via_orthology) | |
| Disease | cortical thickness | AGBL4 CUL9 MACF1 USP35 ADGRV1 CAMTA1 ECE1 KIF20B TFDP2 PDZD2 | 5.02e-04 | 1113 | 75 | 10 | EFO_0004840 |
| Disease | cortical surface area measurement | CACNA2D1 SEMA3C GPR137B CUL9 MACF1 CACHD1 USP35 ADGRV1 KIF20B TFDP2 PDZD2 | 5.68e-04 | 1345 | 75 | 11 | EFO_0010736 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.19e-04 | 152 | 75 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | MYELODYSPLASTIC SYNDROME | 6.72e-04 | 67 | 75 | 3 | C3463824 | |
| Disease | Huntington's disease (biomarker_via_orthology) | 7.48e-04 | 16 | 75 | 2 | DOID:12858 (biomarker_via_orthology) | |
| Disease | Congenital Intestinal Aganglionosis | 8.46e-04 | 17 | 75 | 2 | C3661523 | |
| Disease | intellectual disability (implicated_via_orthology) | 9.34e-04 | 75 | 75 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 9.41e-04 | 295 | 75 | 5 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | Bone marrow hypocellularity | 9.50e-04 | 18 | 75 | 2 | C1855710 | |
| Disease | ovulation | 1.06e-03 | 19 | 75 | 2 | GO_0030728 | |
| Disease | hyperglycemia (biomarker_via_orthology) | 1.30e-03 | 21 | 75 | 2 | DOID:4195 (biomarker_via_orthology) | |
| Disease | systemic scleroderma (is_implicated_in) | 1.70e-03 | 24 | 75 | 2 | DOID:418 (is_implicated_in) | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 1.70e-03 | 24 | 75 | 2 | DOID:1184 (biomarker_via_orthology) | |
| Disease | Fanconi Anemia | 1.84e-03 | 25 | 75 | 2 | C0015625 | |
| Disease | upper face morphology measurement | 1.96e-03 | 97 | 75 | 3 | EFO_0010949 | |
| Disease | Pancytopenia | 1.99e-03 | 26 | 75 | 2 | C0030312 | |
| Disease | methionine measurement | 1.99e-03 | 26 | 75 | 2 | EFO_0009771 | |
| Disease | Acute monocytic leukemia | 1.99e-03 | 26 | 75 | 2 | C0023465 | |
| Disease | Vitiligo | 2.20e-03 | 101 | 75 | 3 | EFO_0004208 | |
| Disease | immune system disease | 2.31e-03 | 28 | 75 | 2 | EFO_0000540 | |
| Disease | revision of total joint arthroplasty | 2.31e-03 | 28 | 75 | 2 | EFO_0020974 | |
| Disease | corpus callosum central volume measurement | 2.31e-03 | 28 | 75 | 2 | EFO_0010296 | |
| Disease | Miller Dieker syndrome | 2.48e-03 | 29 | 75 | 2 | C0265219 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKNVSYTDQAFFSFV | 101 | O00400 | |
| FSAIDSNKDYTSSFS | 586 | Q9Y6Y1 | |
| SSFRYFQSVDFAAVN | 3491 | Q8WXG9 | |
| TSDFSRFTNYRFKNL | 81 | O96020 | |
| NSFSDRTVQRFYKFN | 891 | Q5VU97 | |
| YAFNADFRKAFSTLL | 331 | P21728 | |
| RTQGYSFFNDAEESK | 126 | Q9UKW6 | |
| ASDYSFSQFKFLQRL | 861 | P98198 | |
| KYKNSEINFSFSRSF | 351 | Q8N3J5 | |
| SEASAFYSLNSFDSK | 91 | P78413 | |
| TSFDFLELNYSFDKN | 376 | Q9Y2R2 | |
| YNFSISSFSKNRFED | 756 | Q9NVI1 | |
| LFTAEYQTSNRFHFK | 126 | Q2M2H8 | |
| EIYFNSFFKDRQRAS | 306 | P59045 | |
| YNSFNDEKSVSSNLF | 946 | Q8IYD8 | |
| KNFFSTKTDYFNETT | 51 | Q9Y231 | |
| NSSYSFESDFDLTKS | 1571 | Q15751 | |
| NKNFLSNYSRNFSSF | 1516 | O15018 | |
| TLFYSFKAEDTNSAQ | 1436 | Q6ZNL6 | |
| FRESKLTHYFQSFFN | 431 | Q96Q89 | |
| SSFDEILAFYNDASK | 146 | Q9ULS6 | |
| SNTTSDFYFEKSANY | 666 | P52848 | |
| NFEVFLSFEDYSNSS | 996 | P50748 | |
| SNTTSDFLFEKSANY | 656 | Q9H3R1 | |
| TAYFQFFSDARELES | 786 | Q9UPN3 | |
| SRQEESTKYFNFATS | 926 | Q13349 | |
| QASESCLFRFFKNSY | 811 | O15118 | |
| FFKSNYADLDSNSDD | 756 | Q9UBK2 | |
| FDSSYDRDSTFNVFV | 71 | O95302 | |
| SSSNLFFKGSRFRYS | 306 | Q7Z6J6 | |
| TEQTQYFFDNDSKSF | 976 | P54289 | |
| YFFDNDSKSFSGVLD | 981 | P54289 | |
| SFESQFLADTERFYT | 231 | Q13616 | |
| QNAEDFSYSSTSFNR | 361 | Q5VU57 | |
| FSYSSTSFNRDAVKA | 366 | Q5VU57 | |
| RDSFSYEKFNFRSNP | 1186 | Q5VV63 | |
| SCSYKDFSESRNNRF | 471 | P14866 | |
| DALDRFSSFYSQSQN | 1726 | Q8IWT3 | |
| FFSVYVSADSKNSNS | 236 | P42892 | |
| TKSEFNFSSKTYQEF | 626 | Q92674 | |
| SRYSAALAESDTFFQ | 206 | Q1W6H9 | |
| NRSYKVSAASSFFFS | 106 | Q8IZD6 | |
| QSYKRKSEQEFSFDT | 1121 | Q99590 | |
| STSASRFQSDKYSFQ | 4381 | Q9NZJ4 | |
| AFTQSRAASYFFDGS | 1041 | Q16363 | |
| STNSRFENYGDKFAE | 311 | Q9BUJ2 | |
| FSFYFKDFVAANSLS | 96 | O60478 | |
| FSTFNDYAFLTAEEK | 491 | Q96DX4 | |
| YFFFKEKLTDNNRST | 241 | Q99985 | |
| FISYSVTFKDNFRQG | 66 | Q9BRQ8 | |
| SYSSYERSFDFTNKQ | 316 | O75603 | |
| SQEDKNFAQSYFDFS | 311 | Q96LK8 | |
| DFLSSFRDSCQKFYQ | 101 | P35237 | |
| FFSSQVGRKSQSAFY | 111 | Q96JF0 | |
| IYKAFRSDNSFSFFV | 206 | O15127 | |
| FAQDSSYFEDFSNIS | 91 | Q9Y2G9 | |
| FESQLSLNFYTNAKF | 151 | Q96PL2 | |
| VQFSTSYKTEFDFSD | 196 | P20701 | |
| SRTSASFSENFYGLK | 76 | O00623 | |
| ISSDKFEYLFNFDNT | 291 | Q14188 | |
| FYFFSESRQEKSNRI | 41 | O95573 | |
| TNDFALYTEAIKFFN | 166 | Q2KHT3 | |
| FRVTQDSLFYSSNEF | 401 | Q12884 | |
| DSERYAQENFKSFIF | 206 | O75333 | |
| LDTVSNVDYFFNFKA | 346 | Q8IZ63 | |
| FRFSTDNDFKSEGKY | 176 | Q96PP4 | |
| SDSFSAFQYDGRKFD | 911 | Q6GYQ0 | |
| TGQSHFKSFDNRYFT | 391 | P04275 | |
| FSRYQTQKQESFFVD | 221 | Q86U17 | |
| YNFDRSSSTFSGIKE | 936 | Q8N3U4 | |
| YLFNDTRVSFSSFES | 891 | Q9P2H5 | |
| NASTDFLFEKSATYF | 666 | P52849 | |
| FRTYDDFSYQTSKEN | 766 | Q7Z4N2 | |
| SYEFKDFEKAFSSSS | 616 | Q6PG37 | |
| SDQDNDKVYFFFSET | 236 | Q9NS98 | |
| FDEAFSQASSYAKQR | 571 | A6NHJ4 | |
| FSIRDYFTFASTFEN | 171 | Q96S15 | |
| KAFNSSSSFRYHERT | 401 | Q8N7K0 | |
| ASNNFFVDDYARFTI | 711 | Q9NYU2 | |
| SSSYFRDLFNNSRSA | 51 | Q96RE7 | |
| ALKEFRQNIFSFYSS | 1896 | B2RTY4 |